Crestor approved for pediatric patients with Heterozygous Familial Hypercholesterolemia - MPR

Links shared publicly online about this topic.

  • 1,672
    total visits

Crestor approved for pediatric patients with Heterozygous Familial Hypercholesterolemia - MPR

empr.com

The FDA has approved Crestor (rosuvastatin calcium tablets, from AstraZeneca) for use in pediatric patients 10"17 years of age with heterozygous familial hypercholesterolemia (HeFH) after failing an adequate trial of diet therapy.

View full resource at empr.com

Tags: Cholesterol Medication, Diet and Nutrition, Mineral, Calcium, Children's Health, FDA, Crestor, AstraZeneca

  • Share

Most Recently Shared on October 16, 2009 at 4:02 pm By:

eMPR MPR

MPR News: Crestor approved for pediatric patients with Heterozygous Familial Hypercholesterolemia : The.. http://bit.ly/1V4B8g

3 years ago...

U.S. Food and Drug Administration Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia

drugs.com — “Crestor (rosuvastatin calcium) is used to treat pediatric patients with heterozygous familial hypercholesterolemia. Includes Crestor side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 10:03 pm By:

drugscom Drugs.com Health Site

FDA Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia - http://bit.ly/DrHi0

3 years ago...

CRESTOR® approved for use in pediatric patients with HeFH

astrazeneca-us.com — “Read how the FDA decision was based on a supplemental New Drug Application submitted by AstraZeneca which included data from the PLUTO study.View full resource at astrazeneca-us.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 1:05 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

FDA approves CRESTOR® for use in pediatric patients with heterozygous familial hypercholesterolemia http://bit.ly/4aRRkt

3 years ago...

Welchol (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia

drugs.com — “Welchol (colesevelam HCl) is used to treat Pediatric Patients with Heterozygous Familial Hypercholesterolemia. Includes Welchol side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 7, 2009 at 10:47 pm By:

drugscom Drugs.com Health Site

FDA Approves Welchol for Pediatric Patients with Heterozygous Familial Hypercholesterolemia - http://bit.ly/BU6lG

3 years ago...

Advertisement